Shen-Meng Gao
Overview
Explore the profile of Shen-Meng Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li T, Li X, Chen H, Huang K, Xie Q, Ge H, et al.
Cancer Manag Res
. 2021 Feb;
13:1233-1243.
PMID: 33603469
Purpose: Red blood cell distribution width (RDW) has been considered as a potential indicator of the effects of treatment or as a prognostic indicator for various malignancies. Most chronic myeloid...
2.
Lei H, Xu H, Shan H, Liu M, Lu Y, Fang Z, et al.
Nat Commun
. 2021 Jan;
12(1):51.
PMID: 33397955
Identifying novel drug targets to overcome resistance to tyrosine kinase inhibitors (TKIs) and eradicating leukemia stem/progenitor cells are required for the treatment of chronic myelogenous leukemia (CML). Here, we show...
3.
Xing C, Li H, Wu J, Gao S
Leuk Lymphoma
. 2015 Dec;
57(7):1743-5.
PMID: 26701108
No abstract available.
4.
Xing C, Hu X, Xie F, Yu Z, Li H, Bin-Zhou , et al.
FEBS Lett
. 2015 May;
589(15):1981-7.
PMID: 25979172
HOTAIR is significantly overexpressed in various cancers and facilitates tumor invasion and metastasis. However, whether HOTAIR plays oncogenic roles in acute myeloid leukemia (AML) is still unknown. Here, we report...
5.
Yang J, Chen H, Zheng X, Li H, Wu J, Tang L, et al.
Asian Pac J Cancer Prev
. 2015 Apr;
16(6):2219-25.
PMID: 25824741
SHP1 negatively regulates the Janus kinase 2/signal transducer and activator of transcription (JAK2/STAT) signaling pathway, which is constitutively activated in myeloproliferative neoplasms (MPNs) and leukemia. Promoter hypermethylation resulting in epigenetic...
6.
Yin L, Zheng X, Li H, Bi L, Shi Y, Ye A, et al.
Leuk Res
. 2015 Feb;
39(4):471-8.
PMID: 25666256
Constitutive activation of Janus kinase 2/signal transducers and activators of transcription (JAK2/STAT) signaling caused by JAK2V617F and other mutations is central to the pathogenesis of myeloproliferative neoplasm (MPN). Negative regulators...
7.
Li H, Ye H, Chen C, Yin L, Wu J, He L, et al.
J Cell Biochem
. 2014 Sep;
116(2):287-98.
PMID: 25187418
Honokiol, a constituent of Magnolia officinalis, has been reported to possess potent anti-cancer activity through targeting multiple signaling pathways in numerous malignancies including acute myeloid leukemia (AML). However, the underlying...
8.
Chen C, Chen C, Chen J, Zhou L, Xu H, Jin W, et al.
Mol Cell Biochem
. 2013 Jul;
383(1-2):137-48.
PMID: 23867991
Histone deacetylases (HDACs) inhibitor is a promising new approach to the treatment of lung cancer therapy via inhibiting cell growth and inducing apoptosis. miR-15a and miR-16-1 are important tumor suppressors...
9.
Luo S, Yu K, Yan Q, Shen Z, Wu J, Chen H, et al.
Leuk Lymphoma
. 2013 Apr;
55(2):349-57.
PMID: 23550990
The single nucleotide polymorphism (SNP) rs16754 of the WT1 gene has been described as a possible prognostic marker in patients with acute myeloid leukemia (AML). However, the results in this...
10.
Chen C, Yu K, Yan Q, Xing C, Chen Y, Yan Z, et al.
Carcinogenesis
. 2013 Feb;
34(7):1442-9.
PMID: 23430957
Suppressors of cytokine signaling, SOCS1 and SOCS3, are important negative regulators of Janus kinase 2/signal transducers and activators of transcription signaling, which is constitutively activated in myeloproliferative neoplasms (MPNs) and...